JCB logo
R&D Systems
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 16 May 2005. doi:10.1083/jcb.200412101
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 169, Number 4, 577-589
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, S.
Right arrow Articles by Casaccia-Bonnefil, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, S.
Right arrow Articles by Casaccia-Bonnefil, P.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Article

Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain

Siming Shen, Jiadong Li, and Patrizia Casaccia-Bonnefil

Department of Neuroscience and Cell Biology, R. Wood Johnson Medical School, Piscataway, NJ 08854

Correspondence to Patrizia Casaccia-Bonnefil: casaccpa{at}umdnj.edu

Timely differentiation of progenitor cells is critical for development. In this study we asked whether global epigenetic mechanisms regulate timing of progenitor cell differentiation into myelin-forming oligodendrocytes in vivo. Histone deacetylation was essential during a specific temporal window of development and was dependent on the enzymatic activity of histone deacetylases, whose expression was detected in the developing corpus callosum. During the first 10 postnatal days, administration of valproic acid (VPA), the specific inhibitor for histone deacetylase activity, resulted in significant hypomyelination with delayed expression of late differentiation markers and retained expression of progenitor markers. Differentiation resumed in VPA-injected rats if a recovery period was allowed. Administration of VPA after myelination onset had no effect on myelin gene expression and was consistent with changes of nucleosomal histones from reversible deacetylation to more stable methylation and chromatin compaction. Together, these data identify global modifications of nucleosomal histones critical for timing of oligodendrocyte differentiation and myelination in the developing corpus callosum.

Abbreviations used in this paper: AcH3, acetylated histone H3; AcLys, acetyl-lysine; CGT, ceramide-galactosyl-transferase; HAT, histone acetyltransferase; HDAC, histone deacetylase; MAG, myelin-associated glycoprotein; MBP, myelin basic protein; MeK9H3, methylated lysine 9 on histone H3; OL, oligodendrocyte; TSA, trichostatin A; VPA, valproic acid.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Deacetylate to differentiate
Nicole LeBrasseur
J. Cell Biol. 2005 169: 548. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents